Search research articles
Contact Us
Filters
Showing results (151-160 of 220) with videos related to
Page
of 22
Sort By:
Haematologica
|
December 6, 2018
T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development
Charles E de Bock, Michelle Down, Kinsha Baidya, et al.
Journal of Chemical Theory and Computation
|
January 19, 2024
Neural Network Corrections to Intermolecular Interaction Terms of a Molecular Force Field Capture Nuclear Quantum Effects in Calculations of Liquid Thermodynamic Properties
Igor V Kurnikov, Leonid Pereyaslavets, Ganesh Kamath, et al.
Pediatric Blood & Cancer
|
January 23, 2016
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program
Richard Gorlick, E Anders Kolb, Stephen T Keir, et al.
Blood Advances
|
April 8, 2021
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL
Alessandra Di Grande, Sofie Peirs, Paul D Donovan, et al.
International Journal of Cancer
|
July 21, 2019
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia
Klaartje Somers, Angelika Kosciolek, Angelika Bongers, et al.
Pediatric Blood & Cancer
|
June 20, 2023
In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenografts
Keira Hughes, Kathryn Evans, Eric J Earley, et al.
Leukemia
|
April 8, 2014
Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC
S J Busfield, M Biondo, M Wong, et al.
Nature Communications
|
December 5, 2020
Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
Cedric S Tremblay, Sung Kai Chiu, Jesslyn Saw, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Stage 2 combination testing of rapamycin with cytotoxic agents by the Pediatric Preclinical Testing Program
Peter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Nature Communications
|
February 20, 2021
Author Correction: Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
Cedric S Tremblay, Sung Kai Chiu, Jesslyn Saw, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 220) with videos related to
Sort By:
Page
of 22
Haematologica
|
December 6, 2018
T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development
Charles E de Bock, Michelle Down, Kinsha Baidya, et al.
Journal of Chemical Theory and Computation
|
January 19, 2024
Neural Network Corrections to Intermolecular Interaction Terms of a Molecular Force Field Capture Nuclear Quantum Effects in Calculations of Liquid Thermodynamic Properties
Igor V Kurnikov, Leonid Pereyaslavets, Ganesh Kamath, et al.
Pediatric Blood & Cancer
|
January 23, 2016
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program
Richard Gorlick, E Anders Kolb, Stephen T Keir, et al.
Blood Advances
|
April 8, 2021
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL
Alessandra Di Grande, Sofie Peirs, Paul D Donovan, et al.
International Journal of Cancer
|
July 21, 2019
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia
Klaartje Somers, Angelika Kosciolek, Angelika Bongers, et al.
Pediatric Blood & Cancer
|
June 20, 2023
In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenografts
Keira Hughes, Kathryn Evans, Eric J Earley, et al.
Leukemia
|
April 8, 2014
Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC
S J Busfield, M Biondo, M Wong, et al.
Nature Communications
|
December 5, 2020
Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
Cedric S Tremblay, Sung Kai Chiu, Jesslyn Saw, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Stage 2 combination testing of rapamycin with cytotoxic agents by the Pediatric Preclinical Testing Program
Peter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Nature Communications
|
February 20, 2021
Author Correction: Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
Cedric S Tremblay, Sung Kai Chiu, Jesslyn Saw, et al.
Page
of 22